Meeting
2013 ASCO Annual Meeting
Predictive values of (18)f-FDG PET standardized uptake value for adjuvant chemotherapy in patients with nasopharyngeal carcinoma.
Authors
Ching Chan Lin
Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
Ching Chan Lin , Te-Chun Hsieh , Tzu-Ting Chen , Ching-Yun Hsieh , Chen-Yuan Lin , Hsin-Hui Huang , Li-Yuan Bai , Po-Han Lin , Chang-Fang Chiu , Su-Peng Yeh , Yu-Min Liao , Woei-Chung Lo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Head and Neck Cancer
Citation
J Clin Oncol 31, 2013 (suppl; abstr 6052)
DOI
10.1200/jco.2013.31.15_suppl.6052
Abstract #
6052
Poster Bd #
11H
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Impact of adjuvant chemotherapy and cumulative cisplatin dose in locally-advanced nasopharyngeal carcinoma (LA-NPC) treated with definitive chemoradiotherapy.
First Author: Marc Oliva Bernal
Poster
2014 ASCO Annual Meeting
Comparison of concurrent chemoradiation therapy with 3-weekly versus weekly cisplatin in patients with locally advanced nasopharyngeal cancer: A multicenter randomized phase II noninferiority trial (KCSG-HN10-02).
First Author: Ji Yun Lee
Poster
2021 ASCO Annual Meeting
Cisplatin and capecitabine induction chemotherapy in nasopharyngeal carcinoma.
First Author: Zhiyuan Xu
Poster
2019 ASCO Annual Meeting
Safety and efficacy of docetaxel combined with cisplatin as induction chemotherapy followed by cisplatin concurrent chemoradiotherapy plus gemcitabine as adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A prospective and multicenter phase II trial.
First Author: Zhi Hui Wang